chenodeoxycholic acid has been researched along with Endometrial Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andò, S; Avena, P; Casaburi, I; Catalano, S; Giordano, F; Lanzino, M; Maris, P; Morelli, C; Sisci, D | 1 |
Akerlund, M; Breeze, A; Filipowska, D; Filipowski, T; Kazanowska, W; Lapinjoki, S; Laudanski, T; Morelowska, B | 1 |
1 trial(s) available for chenodeoxycholic acid and Endometrial Neoplasms
Article | Year |
---|---|
Treatment of cancer patients with a low-density-lipoprotein delivery vehicle containing a cytotoxic drug.
Topics: Adenocarcinoma; Adrenal Cortex; Chenodeoxycholic Acid; Cystadenocarcinoma; Drug Carriers; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Lipoproteins, LDL; Liver; Ovarian Neoplasms; Prednisolone; Time Factors; Vincristine | 1992 |
1 other study(ies) available for chenodeoxycholic acid and Endometrial Neoplasms
Article | Year |
---|---|
Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances cyclin D1 expression and promotes human endometrial cancer cell proliferation.
Topics: Cell Line, Tumor; Cell Proliferation; Chenodeoxycholic Acid; Cyclic AMP Response Element-Binding Protein; Cyclin D1; Endometrial Neoplasms; Female; Gastrointestinal Agents; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutagenesis, Site-Directed; Promoter Regions, Genetic; Receptors, G-Protein-Coupled; RNA Interference; RNA, Small Interfering; Signal Transduction; Up-Regulation | 2012 |